Literature DB >> 24261359

Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.

Kumaresan Sandrasegaran1, Bilal Tahir, Kavitha Nutakki, Fatih M Akisik, Uttam Bodanapally, Mark Tann, Naga Chalasani.   

Abstract

OBJECTIVE: The objective of our study was to determine the value of diffusion-weighted imaging (DWI) and conventional MRI (non-DWI sequences) in differentiating benign portal vein thrombus (PVT) from malignant PVT in cirrhotic patients.
MATERIALS AND METHODS: A retrospective search of the department of radiology's MRI database of examinations performed from October 2006 through December 2010 for "portal vein thrombosis" and "cirrhosis" and "hepatocellular cancer" was performed. Patients who underwent diagnostic DWI and had thrombus shown to be rapidly (< 3 months) increasing in size despite anticoagulation therapy were considered to have malignant PVT (n = 16 cases) and patients with MRI findings showing stability or reduction in the extent of thrombus over a 12-month follow-up were considered to have benign PVT (n = 20 cases). Two blinded and independent reviewers analyzed the DW images and conventional MR images.
RESULTS: There was no difference in the distribution of patients by age (p = 0.25) or sex (p = 0.68) between the benign and malignant PVT groups. On multivariate analysis, the only parameter to predict the type of PVT was the size of HCC (p = 0.05); other parameters were excluded from the model. There was substantial overlap in apparent diffusion coefficient (ADC) values and PVT/liver ADC ratios of benign PVT and malignant PVT. The presence of at least two of the three following MRI findings had a sensitivity of 100% and specificity of 90% for the diagnosis of malignant PVT: distance from tumor to PVT of less than 2 cm, HCC size of greater than 5 cm, and arterial enhancement of PVT.
CONCLUSION: Signal-intensity characteristics on DWI and measured ADC values do not reliably differentiate benign PVT from malignant PVT. On the other hand, careful assessment of conventional MRI findings may allow this distinction, thus obviating biopsy.

Entities:  

Mesh:

Year:  2013        PMID: 24261359     DOI: 10.2214/AJR.12.10171

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  20 in total

Review 1.  LI-RADS and transplantation: challenges and controversies.

Authors:  Guilherme M Cunha; Dorathy E Tamayo-Murillo; Kathryn J Fowler
Journal:  Abdom Radiol (NY)       Date:  2021-01

2.  Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.

Authors:  Chetana Lim; Philippe Compagnon; Mylène Sebagh; Chady Salloum; Julien Calderaro; Alain Luciani; Gérard Pascal; Alexis Laurent; Eric Levesque; Umberto Maggi; Cyrille Feray; Daniel Cherqui; Denis Castaing; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2015-05-16       Impact factor: 3.647

3.  MRI in differentiating malignant versus benign portal vein thrombosis in patients with hepatocellular carcinoma: Value of post contrast imaging with subtraction.

Authors:  Rakhee Gawande; Hamed Jalaeian; Eric Niendorf; Deniz Olgun; Luke Krystosek; Nathan Rubin; Benjamin Spilseth
Journal:  Eur J Radiol       Date:  2019-07-08       Impact factor: 3.528

4.  Multiparametric MRI in differentiating pulmonary artery sarcoma and pulmonary thromboembolism: a preliminary experience.

Authors:  Min Liu; Chunhai Luo; Ying Wang; Xiaojuan Guo; Zhanhong Ma; Yuanhua Yang; Tianjing Zhang
Journal:  Diagn Interv Radiol       Date:  2017 Jan-Feb       Impact factor: 2.630

Review 5.  Tumor in vein (LR-TIV) and liver imaging reporting and data system (LI-RADS) v2018: diagnostic features, pitfalls, prognostic and management implications.

Authors:  Roberta Catania; Kalina Chupetlovska; Amir A Borhani; Ekta Maheshwari; Alessandro Furlan
Journal:  Abdom Radiol (NY)       Date:  2021-09-14

Review 6.  Portal Vein Thrombosis in Cirrhosis.

Authors:  Akash Shukla; Suprabhat Giri
Journal:  J Clin Exp Hepatol       Date:  2021-11-22

7.  Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors.

Authors:  Laura Prakash; Jeffrey E Lee; James Yao; Priya Bhosale; Aparna Balachandran; Huamin Wang; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2015-08-18       Impact factor: 3.452

Review 8.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

9.  Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria.

Authors:  Courtney B Sherman; Spencer Behr; Jennifer L Dodge; John P Roberts; Francis Y Yao; Neil Mehta
Journal:  Liver Transpl       Date:  2019-02       Impact factor: 5.799

10.  Changing Patterns of Hepatocellular Carcinoma after Treatment with Direct Antiviral Agents.

Authors:  Mohammed El Fayoumie; Mahmoud Abdelhady; Ahmed Gawish; Usama Hantour; Ismail Abdelkhaleek; Mohamed Abdelraheem; Alaa Alsawak; Ahmed Alwassief; Ashraf Elbahrawy
Journal:  Gastrointest Tumors       Date:  2020-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.